Patients First Act of 2018 (S 2956, 115th Congress)
Promotes and facilitates stem cell research showing evidence of substantial clinical benefit to patients, while placing restrictions on the creation, injury, and destruction of embryos for such research.
The Sacramento Bee - The California stem cell agency on Wednesday completed creation of a $30 million effort to dramatically speed approval of stem cell therapies and establish the Golden State globally in the much-heralded regenerative medicine field.
CNN - Stem cells have the potential to divide and develop into many different cell types in the body. They are so enchanting and so promising -- that they have Food and Drug Administration officials scratching their heads.
MIT Technology Review – No field of biotechnology has promised more and delivered less in the way of treatments than embryonic stem cells. Only a handful of human studies has ever been carried out, without significant results.